Bactericidal activity of moxifloxacin compared to grepafloxacin and clarithromycin against Streptococcus pneumoniae and Streptococcus pyogenes investigated using an in vitro pharmacodynamic model

Journal of Chemotherapy

Volumn 12, Issue 6, 2000, Pages 475-481

  Esposito, S ^a   Noviello, S ^a   Ianniello, F ^a  

^a Ospedale Gesu e Maria   (Italy)

Author keywords

Fluoroquinolones; Grepafloxacin; Macrolides; Moxifloxacin; Pharmacodynamic; Strept ococcus pneumoniae

Indexed keywords

CLARITHROMYCIN; ERYTHROMYCIN; GREPAFLOXACIN; MACROLIDE; MOXIFLOXACIN; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COUNT; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; EXPERIMENTAL MODEL; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

EID: 0034517625     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2000.12.6.475     Document Type: Article

References (20)

1. A multicentre collaborative study of the antimicrobial susceptibility of community acquired lower respiratory tract pathogens 1992-93. The Alexander Project
2. Activity of Moxifloxacin and 12 other antimicrobial agents against 216 Streptococcus pneurnonaie isolates
3. Erythromycin resistance in Group A β-Haemolytic Streptococcus
4. Killing and regrowth of bacteria in vitro: A review
5. Correlation between pharmacokinetics, pharamacodynamics and efficacy of antibacterial agents in animal models
6. In vitro activity of BAY 12-8039, a new fluoroquinolone
7. In vitro activity of BAY 12-8039, a novel 8-methoxyquinolone, compared to activities of six fluoroquinolones against Streptococcus pneurnoniae, Haemophilus influenzae and Moraxella catarrhalis
8. Antipneumococcal activity of BAY 12-8039, a new quinolone, compared with activities of three other quinolones and four β-lactams
9. In vitro activity of Bay 12-8039, a new 8-methoxyquinolone
10. In vitro activity of BAY 12-8039, a new fluoroquinolone, against species representative of respiratory tract pathogens
11. National Committee for Clinical Laboratory Standards (NCCLS) Methods for dilution antimicrobial tests for bacteria that grow aerobically approved standards
12. New in vitro model to study the effect of antibiotic concentration and rate of elimination of antimicrobial activity
13. Pharmacodynamic activity of Moxifloxacin in an in vitro model against Gram positive and Gram negative pathogens
14. Pharmacodynamic activity of grepafloxacin and macrolides in an in vitro model against respiratory tract pathogens
15. Penetration of clarithromycin into oral and respiratory tissues
16. Pharmacokinetics of grepafloxacin
17. Pharmacodynamics of fluoroquinolones in experimental animals
18. In vitro pharmacodynamics of piperacillin, piperacillin-tazobactam and ciprofloxacin alone and in combination against Staphylococcus aureus, Klebsiella pneumoniae-Entero-bacter cloacae and Pseudomonas aeruginosa
19. Pharmacodynamics of fluoroquinolones